Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00761462 · ClinicalTrials.gov registry record · Phase 3
BAY 0 9867 Cipro Pediatric Use Study (QUIP)
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,029
- Enrollment target
NCT00761462: Completed Phase 3 study, sponsored by Bayer.
NCT00761462 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 1,029 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00761462, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,029 participants
- Enrollment target
Study Summary
Objective and subjective musculoskeletal evaluations will be performed to determine differences in the ciprofloxacin versus non-quinolone treated pediatric patients so that we can tell what the natural occurrence of such musculoskeletal conditions is in the general pediatric population.
Primary Outcome
Arthropathy, as assessed by independent safety committee. The committee, after reviewing data related to musculoskeletal events, decided whether each patient had arthropathy or not. Each incidence includes number shown at previous time point, plus any new patients with the event. The 112/20 arthropathies are mentioned in the other Adverse Events section as well.
Interventions
- DRUG Ciprofloxacin
- DRUG Non-quinolone antibiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,029 participants |
| Start Date | 1999-10 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
What the finished NCT00761462 record still lists
NCT00761462 is an interventional study that assigns participants to a tested intervention. Its 1,029 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 2 interventions - of which Ciprofloxacin is the first listed.
NCT00761462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00761462 about?
NCT00761462 is a clinical study titled "BAY 0 9867 Cipro Pediatric Use Study (QUIP)". Objective and subjective musculoskeletal evaluations will be performed to determine differences in the ciprofloxacin versus non-quinolone treated pediatric patients so that we can tell what the natural occurrence of such musculoskeletal conditions is in the general pediatric population.
What is the current status of trial NCT00761462?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,029 participants. The study started on 1999-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00761462?
The interventions under investigation include: Ciprofloxacin (DRUG), Non-quinolone antibiotic (DRUG).
Who is sponsoring clinical trial NCT00761462?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00761462's enrollment target sits among peer trials
1,029 288th of 2000 higher than 1,713 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia